Active	Status	Sponsor type	Region	Phase	Filter
4 Active 5 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lu AG09222 / Lundbeck
NCT05133323 / 2020-005924-12: A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments	Completed	2	237	Europe, US, RoW	Lu AG09222, Placebo	H. Lundbeck A/S, H. Lundbeck A/S	Migraine	01/23	03/23
2020-005924-12: A Study With Lu AG09222 in Adults With Migraine who Have not Been Helped by Prior Preventive Treatment	Not yet recruiting	2	230	Europe, RoW	Lu AG09222, Lu AG09222, Solution for injection/infusion	H. Lundbeck A/S, H. Lundbeck A/S	Prevention of migraine in patients with unsuccessful prior preventive treatments, Migraine, Diseases [C] - Nervous System Diseases [C10]
PROCEED, NCT06323928: A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments	Recruiting	2	498	Europe, Japan, US, RoW	Lu AG09222, Placebo	H. Lundbeck A/S	Migraine	07/25	09/25
NCT06578585: A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine	Recruiting	1	40	US	Ubrogepant, Lu AG09222, Placebo	H. Lundbeck A/S	Migraine	07/25	07/25